| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | LDO2FIQ61I |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 948570-30-7 |
| ChEMBL | CHEMBL1743066 |
| FDA SRS | LDO2FIQ61I |
| Guide to Pharmacology | 9640 |
CONTENTS